Helpful Videos for Patients with PAH

You're not alone. Hearing from others in the pulmonary arterial hypertension (PAH) community can be an excellent learning tool and a great source of comfort. The following videos feature healthcare teams and patients just like you.

Watch the videos below to learn more about PAH and hear how others are managing the disease.

What is PAH? Video
Living with PAH Video
Taking Tracleer for PAH Video
Sure Steps^™: Patient Education and Support Program Video

What is PAH? Video

PAH specialists Dr. Victor Tapson and Dr. Richard Channick discuss PAH symptoms, impact on blood vessels, effect on the right side of the heart, and syncope (fainting).

Living with PAH Video

Hear patients discuss PAH, living with PAH, good days and bad days, and the importance of setting realistic goals.

Taking Tracleer for PAH Video

Hear patients discuss taking Tracleer and the importance of keeping a positive attitude.

Sure Steps^™ Patient Education and Support Program Video

Hear from other Tracleer patients who are enrolled in Sure Steps, a patient education and support program.


Tracleer is indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in patients with WHO Class II-IV symptoms, to improve exercise ability and decrease the rate of clinical worsening. Patients with WHO Class II symptoms showed reduction in the rate of clinical deterioration and a trend for improvement in walk distance. Physicians should consider whether these potential benefits are sufficient to offset liver injury in WHO Class II patients, which may preclude future use as their disease progresses.

Important safety information

Because of the associated risks, Tracleer may be prescribed only through the Tracleer Access Program.

Potential for serious liver injury (including, after prolonged treatment, rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring)—Liver monitoring of all patients is essential prior to initiation of treatment and monthly thereafter.

High potential for major birth defects—Pregnancy must be excluded and prevented through the use of reliable forms of birth control; monthly pregnancy tests should be obtained.

Contraindicated for use with cyclosporine A and glyburide.

Please see full prescribing information including BOXED WARNING.